Psychopharmacological Interventions in Autism Spectrum Disorder

Feb 23, 2022 | Medicine, Psychology

Scene from the Academy in Copenhagen


Children and adolescents with ASD are more vulnerable to the side effects of psychopharmacological intervention than their age-matched, typically developing counterparts. Currently, risperidone and aripiprazole are the only medications that have been (relatively) reliably shown to help treat certain symptom clusters associated with ASD, namely severely disruptive behavior and hyperactivity. Recent studies have begun to look at medications with mechanisms that are novel in the treatment of ASD and that may address underlying pathophysiology and/or core symptoms such as glutamate-modulating agents.

Taylor & Francis Online > Politte, Laura C. MD; Henry, Charles A. MD; McDougle, Christopher J. MD